Identifying and repurposing antiviral drugs against severe acute respiratory syndrome coronavirus 2 with in silico and in vitro approaches

Coronavirus infectious diseases 2019 (COVID-19), a global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been a serious public health threat worldwide. So far, there are no drugs and vaccines whose efficacy has been well-proven. After the outbreak, there has bee...

Descripción completa

Detalles Bibliográficos
Autor principal: Watashi, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678433/
https://www.ncbi.nlm.nih.gov/pubmed/33272566
http://dx.doi.org/10.1016/j.bbrc.2020.10.094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678433/
https://www.ncbi.nlm.nih.gov/pubmed/33272566
http://dx.doi.org/10.1016/j.bbrc.2020.10.094

Ejemplares similares